Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Babaykina ON"'
Autor:
Nato V. Vashakmadze, Natalia V. Zhurkova, Marina A. Babaykina, Albina V. Dobrotok, Olga B. Gordeeva, Leyla S. Namazova-Baranova
Publikováno v:
Вопросы современной педиатрии, Vol 22, Iss 6, Pp 554-559 (2023)
Background. Hurler syndrome (mucopolysaccharidosis, type I) is a rare hereditary disease with chronic course. The main methods for Hurler syndrome management are hematopoietic stem cell transplantation (HSCT) and enzyme replacement therapy (ERT). In
Externí odkaz:
https://doaj.org/article/99b2bb080d224afc921c4cb512c29ce2
Autor:
Vladimir Yu. Talayev, Maria V. Svetlova, Irina Ye. Zaichenko, Olga N. Babaykina, Elena V. Voronina, Sergey I. Chistyakov
Publikováno v:
Инфекция и иммунитет, Vol 13, Iss 5, Pp 809-821 (2023)
B-cell receptors can interact with antigen epitopes on various objects: macromolecules, microorganisms or on the surface of other cells, e.g., follicular dendritic cells. Accordingly, B cells, on the one hand, have the ability to evaluate the locatio
Externí odkaz:
https://doaj.org/article/63bd94093d0442e0beafc824271d5e74
Autor:
Nato D. Vashakmadze, Nataliya V. Zhurkova, Ekaterina Yu. Zakharova, Ludmila K. Mikhaylova, Marina A. Babaykina
Publikováno v:
Вопросы современной педиатрии, Vol 22, Iss 4, Pp 324-330 (2023)
Background. Mucopolysaccharidosis type II (MPS II, Hunter syndrome) is an X-linked recessive disease caused by lysosomal enzyme iduronate-2-sulfatase deficiency resulting in progressive glycosaminoglycans (GAG) accumulation in tissues (dermatan sulfa
Externí odkaz:
https://doaj.org/article/8937171f657e4f6c9ef6a9ef77a0af3a
Autor:
Nato D. Vashakmadze, Natalia V. Zhurkova, Ludmila K. Mikhaylova, Marina A. Babaykina, Maria S. Karaseva, Kristina V. Pashkova, Ekaterina Yu. Zakharova, Leyla S. Namazova-Baranova
Publikováno v:
Вопросы современной педиатрии, Vol 21, Iss 6S, Pp 577-582 (2023)
Background. Alfa-mannosidosis is ultra-rare autosomal recessive lysosomal storage disease caused by the mutation in the MAN2B1 gene. Pathogenic nucleotide variants and structural changes in this gene lead to acid alpha-mannosidase deficiency, this en
Externí odkaz:
https://doaj.org/article/9d94e098e8e948089f7480e9324172fd
Autor:
Natalia V. Zhurkova, Nato D. Vashakmadze, Ludmila K. Mikhaylova, Marina A. Babaykina, Nina V. Fedorova, Elena Yu. Voskoboeva, Ekaterina Yu. Zakharova, Leyla S. Namazova-Baranova
Publikováno v:
Вопросы современной педиатрии, Vol 21, Iss 6S, Pp 570-576 (2023)
Background. Mucopolysaccharidosis type II (MPS II) is a rare hereditary disease from the group of lysosomal storage diseases, with progressive course. There is effective enzyme replacement therapy (ERT) for this disease, it prevents the development o
Externí odkaz:
https://doaj.org/article/a2f1fa6b03964f108f9c67601e88f1dc
Autor:
Olga B. Gordeeva, Nato D. Vashakmadze, Maria S. Karaseva, Marina A. Babaykina, Natalia V. Zhurkova, Margarita A. Soloshenko, Elena V. Kretova
Publikováno v:
Педиатрическая фармакология, Vol 19, Iss 4, Pp 326-335 (2022)
Background. Hemostatic system pathology is topical and poorly studied issue in pediatrics. One of the main causes of coagulation pathway disorders associated with thrombotic events is abnormality in various parts of the hemostatic system. Vascular ac
Externí odkaz:
https://doaj.org/article/44f2a805b21946699a38d0316b701109
Autor:
Nato D. Vashakmadze, Natalya V. Zhurkova, Olga B. Gordeeva, Elena V. Komarova, Tatyana E. Privalova, Anastasya I. Rykunova, Marina А. Babaykina
Publikováno v:
Вопросы современной педиатрии, Vol 20, Iss 6s, Pp 618-623 (2021)
Mucopolysaccharidosis type II (MPS II; Hunter syndrome) is X-linked hereditary disease from the group of lysosomal storage disease. Its prevalence is 3–7 cases per 1 million live-born boys. MPS II occurs due to the deficiency of iduronate-2-sulfata
Externí odkaz:
https://doaj.org/article/8bcea21d0889433c97c852e58a4410f7
Autor:
Nato D. Vashakmadze, Natalia V. Zhurkova, Leyla S. Namazova-Baranova, Nina V. Fedorova, Marina A. Babaykina
Publikováno v:
Вопросы современной педиатрии, Vol 20, Iss 1, Pp 72-80 (2021)
Background. Mucopolysaccharidosis (MPS) type II is an X-linked hereditary disease from the lysosomal storage diseases group. The absence or malfunctioning of the iduronate-2-sulfatase enzyme leads to disruption in glycosaminoglycans (GAG) degradation
Externí odkaz:
https://doaj.org/article/dabdc5a879d44b1788b655153c532a4c
Autor:
Talayev, Vladimir, Svetlova, Maria, Zaichenko, Irina, Voronina, Elena, Babaykina, Olga, Neumoina, Natalia, Perfilova, Ksenia
Publikováno v:
Helicobacter; May2024, Vol. 29 Issue 3, p1-11, 11p
Autor:
Nina V. Fedorova, Natalia V. Zhurkova, Nato D. Vashakmadze, Marina A. Babaykina, Grigory V. Revunenkov, Kirill V. Savostyanov, Olga B. Gordeeva, Leyla S. Namazova-Baranova
Publikováno v:
Педиатрическая фармакология, Vol 17, Iss 5, Pp 459-466 (2020)
Background. Type II mucolipidosis (I-cell disease, ICD) is one of the lysosomal storage diseases. It is very rare disease; the literature describes only few cases with confirmed diagnosis of mucolipidosis. Cardiovascular changes in children with such
Externí odkaz:
https://doaj.org/article/0084474a21794998a5bad3ea320fbcff